Compounds > gemfibrozil
Page last updated: 2024-10-27

gemfibrozil and Cardiomyopathies

gemfibrozil has been researched along with Cardiomyopathies in 1 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, M1
Hoffman, RS1
Flomenbaum, M1

Other Studies

1 other study available for gemfibrozil and Cardiomyopathies

ArticleYear
Cerivastatin and gemfibrozil-induced cardiac rhabdomyolysis.
    The American journal of forensic medicine and pathology, 2002, Volume: 23, Issue:3

    Topics: Cardiomyopathies; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductas

2002